-
British family bids to row back against suicide taboo
-
Tech firms rally but Asian markets mixed, with eyes on US inflation
-
China's teenage 223cm basketball player 'just a little girl'
-
Nepal holds day of mourning as families pray missing still alive
-
Tokyo's Shinjuku to ban more than half of vacation rentals
-
African players in Europe: Mbeumo fires solo goal as United draw
-
Australian Rules limits contact training to reduce concussion
-
Malaysia cancels haze emergency, but warns problems remain
-
Germany's Merz under pressure from far-right election triumph
-
Philippine sensation Eala looks forward to Asian Games 'fun'
-
Nepal tunnel rescues face 'unprecedented' challenge
-
Jakarta airport extends closure after volcano eruption
-
Mourinho's Real Madrid European revival bid starts with Inter reunion
-
Lonely woman director in Venice sees industry backsliding on gender
-
Solomons PM survives attempt to oust government
-
Tech firms rally on mixed day for Asian markets, with eyes on US inflation
-
Ohtani 'unlikely' to pitch again this season, says Dodgers manager
-
World number one An sends Asian Games warning with China hat-trick
-
Driver thanks 'superhero' rival for saving him from flaming race car
-
PSG go for three in a row as Champions League returns
-
Can dogs sniff cancer? AI joins the hunt in India
-
"Super-human' Alcaraz books US Open quarter-final clash with Shelton
-
Shelton steams into US Open quarter-final clash with Alcaraz
-
ECB set to hike interest rates as Iran war flares anew
-
25 years on, America seeks to keep 9/11 memories alive
-
AI data centers are less thirsty now, tech giants say
-
'Trumpapalooza' tests Republican bet on unpopular US president
-
North Korea vows nuclear-armed navy as US ally drills open
-
Pegula tops Cirstea to reach US Open quarter-finals
-
Under-fire Labuschagne named in Australia Test squad for South Africa
-
Australians could opt out of social media algorithms under new law
-
Best Way to Protect A 401(k) in 2026: Guide Released by Experts
-
Genflow Biosciences PLC Announces Appointment of Investor Relations Adviser
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 07
-
Enjoying the moment: Alcaraz steps it up to reach US Open quarter-finals
-
Tiafoe tops Medvedev in straight sets at US Open
-
Five dead, five injured after Amazon cargo plane overshoots Miami runway
-
Zverev seeks US Open last eight as Osaka faces Rybakina
-
La Rochelle half-backs lead fightback against Toulouse
-
Alcaraz turns up heat to reach US Open quarters
-
US envoys have 'more effective proposals': Ukraine official
-
Gatti salvages Juve draw with AC Milan in Serie A
-
Defending champion Alcaraz powers into US Open quarter-finals
-
Sinayoko stars as unbeaten Paris FC down Marseille
-
Amazon cargo plane overshoots Miami runway, hits vehicles, catches fire
-
Still on top: 'Spider-Man' dominates North American box office
-
Toll from Yemen clashes passes 300 as civilians flee homes
-
Zelensky in fresh talks with US envoys: Ukraine official
-
Sabalenka books US Open quarter-final clash with Noskova
-
Noskova edges Kostyuk to reach US Open quarter-finals
Germans turn to health apps as insurers foot the bill
German doctors are increasingly prescribing smartphone health apps alongside pills and therapy to patients, marking a growing trend towards digital healthcare.
Civil servant Mona Noe, 30, has long kept close watch over her diet in order to reduce cramps and bloating caused by irritable bowel syndrome.
Noe managed to persuade her doctor to prescribe her the app Cara Care, where she receives wellness tips and keeps a food diary to identify her pain triggers.
"It is difficult to do it by yourself," she said, preparing a vegetable stir fry without peppers or tomatoes at her home in Schleiden in western Germany, as per the app's instructions.
"The app has transformed my cooking by helping me avoid certain foods."
Applications that help patients quit smoking, fight obesity or improve their mental health often cost hundreds of euros a month, but insurance companies are helping by footing the bill.
The programme Noe uses is one of 56 now covered by German health insurers, signalling the country's turn towards digital health over traditional pen and paper options.
- 'Around the clock' -
The digital health tools, known as "DiGA" in Germany, have been available on prescription since 2020, typically on three-month renewable subscriptions.
In the five years since the programme began, more than one million prescriptions have been written, according to a study by digital healthcare sector association SVDGV.
Nearly 60 percent of doctors in Germany have prescribed at least one DiGA, and the number of prescriptions written for them in 2024 was up by 85 percent from the previous year.
Johannes Patze, a doctor in Frankfurt, said he prescribes them "almost daily" -- particularly for mental health support while patients are on a waiting list for a therapy appointment.
The apps provide patients with personalised mood tracking, online consultations with professionals, meditation sessions and motivational notifications.
The benefit, Patze said, is that "they're available around the clock, 24/7".
But they come with a cost. A three-month health app subscription costs 600 euros ($705) on average.
Health insurers have paid out 234 million euros for subscription services since 2020.
- 'Easing the burden' -
Germany's Association of Statutory Health Insurance Funds has criticised "excessive" application pricing and warns that there is little hard evidence to back up how effective they are.
But Patze told AFP that the apps could prove a reliable way of lowering healthcare costs in years to come.
Germany spent 326.9 billion euros on healthcare in 2024 -- higher than in previous years and partly due to an ageing population.
"The costs are probably lower in the long run since patients are better taken care of," said Patze.
Digital health consultant Henrik Matthies agreed.
"It's an upfront cost," he said, "but it helps patients get back to work sooner, easing the burden on the healthcare system."
The success of health apps in Germany is partly down to a fast-track approval process that is unusual in a country often mocked for its tedious bureaucracy.
App developers can obtain provisional approval for a programme within three months of applying. They then have a year to demonstrate its clinical effectiveness.
This speedy process "was a catalyst" for the system, Matthies said. Of 228 applications made in the past five years, 43 have received full approval and 13 are still under review.
P.Santos--AMWN